These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29512401)

  • 1. GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems.
    Lee BKB; Gan CP; Chang JK; Tan JL; Fadlullah MZ; Abdul Rahman ZA; Prime SS; Gutkind JS; Liew CS; Khang TF; Tan AC; Cheong SC
    J Dent Res; 2018 Jul; 97(8):909-916. PubMed ID: 29512401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of DNA repair susceptibility genes identified by whole exome sequencing in head and neck cancer.
    Das R; Kundu S; Laskar S; Choudhury Y; Ghosh SK
    DNA Repair (Amst); 2018; 66-67():50-63. PubMed ID: 29747023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling most abundant mutational signatures in head and neck cancer.
    Plath M; Gass J; Hlevnjak M; Li Q; Feng B; Hostench XP; Bieg M; Schroeder L; Holzinger D; Zapatka M; Freier K; Weichert W; Hess J; Zaoui K
    Int J Cancer; 2021 Jan; 148(1):115-127. PubMed ID: 32930393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MethCNA: a database for integrating genomic and epigenomic data in human cancer.
    Deng G; Yang J; Zhang Q; Xiao ZX; Cai H
    BMC Genomics; 2018 Feb; 19(1):138. PubMed ID: 29433427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer.
    Xu C; Nikolova O; Basom RS; Mitchell RM; Shaw R; Moser RD; Park H; Gurley KE; Kao MC; Green CL; Schaub FX; Diaz RL; Swan HA; Jang IS; Guinney J; Gadi VK; Margolin AA; Grandori C; Kemp CJ; Méndez E
    Clin Cancer Res; 2018 Jun; 24(12):2828-2843. PubMed ID: 29599409
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.
    Cheng H; Yang X; Si H; Saleh AD; Xiao W; Coupar J; Gollin SM; Ferris RL; Issaeva N; Yarbrough WG; Prince ME; Carey TE; Van Waes C; Chen Z
    Cell Rep; 2018 Oct; 25(5):1332-1345.e5. PubMed ID: 30380422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
    Nickerson ML; Witte N; Im KM; Turan S; Owens C; Misner K; Tsang SX; Cai Z; Wu S; Dean M; Costello JC; Theodorescu D
    Oncogene; 2017 Jan; 36(1):35-46. PubMed ID: 27270441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
    BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.
    Woo XY; Srivastava A; Graber JH; Yadav V; Sarsani VK; Simons A; Beane G; Grubb S; Ananda G; Liu R; Stafford G; Chuang JH; Airhart SD; Karuturi RKM; George J; Bult CJ
    BMC Med Genomics; 2019 Jul; 12(1):92. PubMed ID: 31262303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma.
    Nulton TJ; Olex AL; Dozmorov M; Morgan IM; Windle B
    Oncotarget; 2017 Mar; 8(11):17684-17699. PubMed ID: 28187443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease.
    Nisa L; Barras D; Medová M; Aebersold DM; Medo M; Poliaková M; Koch J; Bojaxhiu B; Eliçin O; Dettmer MS; Angelino P; Giger R; Borner U; Caversaccio MD; Carey TE; Ho L; McKee TA; Delorenzi M; Zimmer Y
    Mol Cancer Res; 2018 Dec; 16(12):1912-1926. PubMed ID: 30108165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures.
    Zhang Y; Koneva LA; Virani S; Arthur AE; Virani A; Hall PB; Warden CD; Carey TE; Chepeha DB; Prince ME; McHugh JB; Wolf GT; Rozek LS; Sartor MA
    Clin Cancer Res; 2016 Sep; 22(18):4735-45. PubMed ID: 27091409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide somatic copy number alteration analysis and database construction for cervical cancer.
    Luo H; Xu X; Yang J; Wang K; Wang C; Yang P; Cai H
    Mol Genet Genomics; 2020 May; 295(3):765-773. PubMed ID: 31901979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudogene Transcripts in Head and Neck Cancer: Literature Review and
    Carron J; Della Coletta R; Lourenço GJ
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
    Schmitt K; Molfenter B; Laureano NK; Tawk B; Bieg M; Hostench XP; Weichenhan D; Ullrich ND; Shang V; Richter D; Stögbauer F; Schroeder L; de Bem Prunes B; Visioli F; Rados PV; Jou A; Plath M; Federspil PA; Thierauf J; Döscher J; Weissinger SE; Hoffmann TK; Wagner S; Wittekindt C; Ishaque N; Eils R; Klussmann JP; Holzinger D; Plass C; Abdollahi A; Freier K; Weichert W; Zaoui K; Hess J
    Int J Cancer; 2019 Dec; 145(12):3299-3310. PubMed ID: 31135957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
    Wang X; Yin Z; Zhao Y; He M; Dong C; Zhong M
    Mol Med Rep; 2020 Mar; 21(3):1647-1657. PubMed ID: 32016476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenomic portals for the visualization and analysis of genome-wide cancer data.
    Klonowska K; Czubak K; Wojciechowska M; Handschuh L; Zmienko A; Figlerowicz M; Dams-Kozlowska H; Kozlowski P
    Oncotarget; 2016 Jan; 7(1):176-92. PubMed ID: 26484415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy.
    Lepikhova T; Karhemo PR; Louhimo R; Yadav B; Murumägi A; Kulesskiy E; Kivento M; Sihto H; Grénman R; Syrjänen SM; Kallioniemi O; Aittokallio T; Wennerberg K; Joensuu H; Monni O
    Mol Cancer Ther; 2018 Sep; 17(9):2060-2071. PubMed ID: 29970484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.